Response to antipsychotic drugs in treatment-resistant schizophrenia : Conclusions based on systematic review

Molins, C.Roldan, A.Corripio, I.Isohanni, M.Miettunen, J.Seppala, J.Seppala, A.Koponen, HannuMoilanen, J.Jaaskelainen, E.M-RESIST Grp2018-03-082025-08-262016-12Molins, C, Roldan, A, Corripio, I, Isohanni, M, Miettunen, J, Seppala, J, Seppala, A, Koponen, H, Moilanen, J, Jaaskelainen, E & M-RESIST Grp 2016, 'Response to antipsychotic drugs in treatment-resistant schizophrenia : Conclusions based on systematic review', Schizophrenia Research, vol. 178, no. 1-3, pp. 64-67. https://doi.org/10.1016/j.schres.2016.09.016ORCID: /0000-0002-7368-1869/work/31015763http://hdl.handle.net/10138/2333034enginfo:eu-repo/semantics/openAccessTreatment-resistant schizophreniaAntipsychoticResponseEfficacyClozapineReviewHIGH-DOSE OLANZAPINEDOUBLE-BLINDCLOZAPINECHLORPROMAZINEMETAANALYSISRISPERIDONEQUETIAPINEEFFICACYTRIALSNeurology and psychiatryResponse to antipsychotic drugs in treatment-resistant schizophrenia : Conclusions based on systematic reviewReview ArticleopenAccess2861cb35-c960-467e-b2a8-002188c26a2b85006127502000393048700012